Cardiovascular implantable device infections
- PMID: 21484218
- DOI: 10.1007/s11908-011-0187-7
Cardiovascular implantable device infections
Abstract
As life expectancy continues to increase and biotechnology advances, the use of cardiovascular implantable devices will continue to rise. Unfortunately, despite modern medical advances, the infection and mortality rates remain excessively elevated. This article reviews the pathophysiology and general concepts of cardiac device-related infections, including the physical and chemical characteristics of the medical device, host response to the medical device, and the microbiologic virulence factors. Infections of the most commonly utilized cardiovascular implantable devices, including cardiovascular implantable electronic devices, bioprosthetic and mechanical valves, ventricular assist devices, total artificial hearts, and coronary artery stents, are reviewed in detail.
Similar articles
-
Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.Eur J Heart Fail. 2019 Sep;21(9):1129-1141. doi: 10.1002/ejhf.1568. Epub 2019 Aug 13. Eur J Heart Fail. 2019. PMID: 31410955
-
Management of bacteremia in patients living with cardiovascular implantable electronic devices.Heart Rhythm. 2016 Nov;13(11):2247-2252. doi: 10.1016/j.hrthm.2016.08.029. Epub 2016 Aug 19. Heart Rhythm. 2016. PMID: 27546815 Review.
-
Prevention, Diagnosis, and Treatment of Cardiac Implantable Electronic Device Infections.Curr Cardiol Rep. 2016 Jun;18(6):58. doi: 10.1007/s11886-016-0733-x. Curr Cardiol Rep. 2016. PMID: 27147510 Review.
-
Left ventricular assist devices: an evidence-based analysis.Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1. Ont Health Technol Assess Ser. 2004. PMID: 23074453 Free PMC article.
-
Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections.J Cardiovasc Electrophysiol. 2014 Nov;25(11):1199-205. doi: 10.1111/jce.12461. Epub 2014 Jul 8. J Cardiovasc Electrophysiol. 2014. PMID: 24890850
Cited by
-
Antibacterial Designs for Implantable Medical Devices: Evolutions and Challenges.J Funct Biomater. 2022 Jun 21;13(3):86. doi: 10.3390/jfb13030086. J Funct Biomater. 2022. PMID: 35893454 Free PMC article. Review.
-
A review on antimicrobial strategies in mitigating biofilm-associated infections on medical implants.Curr Res Microb Sci. 2024 Mar 7;6:100231. doi: 10.1016/j.crmicr.2024.100231. eCollection 2024. Curr Res Microb Sci. 2024. PMID: 38510214 Free PMC article. Review.
-
Case Report: Moderate-to-severe paravalvular leak regurgitation after recurrent prosthetic valve endocarditis in a patient with a double-chambered right ventricle associated with a restricted membranous ventricular septal defect.Front Cardiovasc Med. 2025 May 14;12:1558686. doi: 10.3389/fcvm.2025.1558686. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40438230 Free PMC article.
-
Polymer-Based Bioorthogonal Nanocatalysts for the Treatment of Bacterial Biofilms.J Am Chem Soc. 2020 Jun 17;142(24):10723-10729. doi: 10.1021/jacs.0c01758. Epub 2020 Jun 8. J Am Chem Soc. 2020. PMID: 32464057 Free PMC article.
-
Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical Devices.Biomed Res Int. 2016;2016:1851242. doi: 10.1155/2016/1851242. Epub 2016 Oct 31. Biomed Res Int. 2016. PMID: 27872845 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Research Materials